Disturbances in microbial skin recolonization and cutaneous immune response following allogeneic stem cell transfer.


Journal

Leukemia
ISSN: 1476-5551
Titre abrégé: Leukemia
Pays: England
ID NLM: 8704895

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 05 05 2022
accepted: 15 09 2022
revised: 09 09 2022
pubmed: 13 10 2022
medline: 1 11 2022
entrez: 12 10 2022
Statut: ppublish

Résumé

The composition of the gut microbiome influences the clinical course after allogeneic hematopoietic stem cell transplantation (HSCT), but little is known about the relevance of skin microorganisms. In a single-center, observational study, we recruited a cohort of 50 patients before undergoing conditioning treatment and took both stool and skin samples up to one year after HSCT. We could confirm intestinal dysbiosis following HSCT and report that the skin microbiome is likewise perturbed in HSCT-recipients. Overall bacterial colonization of the skin was decreased after conditioning. Particularly patients that developed acute skin graft-versus-host disease (aGVHD) presented with an overabundance of Staphylococcus spp. In addition, a loss in alpha diversity was indicative of aGVHD development already before disease onset and correlated with disease severity. Further, co-localization of CD45

Identifiants

pubmed: 36224329
doi: 10.1038/s41375-022-01712-z
pii: 10.1038/s41375-022-01712-z
doi:

Types de publication

Observational Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2705-2714

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Gallo RL. Human Skin Is the Largest Epithelial Surface for Interaction with Microbes. The. J investigative Dermatol. 2017;137:1213–4.
doi: 10.1016/j.jid.2016.11.045
Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011;9:244–53.
pubmed: 21407241 pmcid: 3535073 doi: 10.1038/nrmicro2537
Kabashima K, Honda T, Ginhoux F, Egawa G. The immunological anatomy of the skin. Nat Rev Immunol. 2019;19:19–30.
pubmed: 30429578 doi: 10.1038/s41577-018-0084-5
Brown VI. HSCT-Associated Complications of the Skin, Hair, and Nails. In: Brown VI, editor. Hematopoietic Stem Cell Transplantation for the Pediatric Hematologist/Oncologist. Cham: Springer International Publishing; 2018. p. 363-8.
Zeiser R, Blazar BR. Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy. N. Engl J Med. 2017;377:2167–79.
pubmed: 29171820 pmcid: 6034180 doi: 10.1056/NEJMra1609337
Strobl J, Pandey RV, Krausgruber T, Bayer N, Kleissl L, Reininger B, et al. Long-term skin-resident memory T cells proliferate in situ and are involved in human graft-versus-host disease. Sci Transl Med. 2020;12:eabb7028.
pubmed: 33208504 doi: 10.1126/scitranslmed.abb7028
Strong Rodrigues K, Oliveira-Ribeiro C, de Abreu Fiuza Gomes S, Knobler R. Cutaneous Graft-Versus-Host Disease: Diagnosis and Treatment. Am J Clin Dermatol. 2018;19:33–50.
pubmed: 28656563 doi: 10.1007/s40257-017-0306-9
Mathewson N, Reddy P. The Microbiome and Graft Versus Host Disease. Curr Stem Cell Rep. 2015;1:39–47.
doi: 10.1007/s40778-014-0002-0
Taur Y, Jenq RR, Perales MA, Littmann ER, Morjaria S, Ling L, et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood. 2014;124:1174–82.
pubmed: 24939656 pmcid: 4133489 doi: 10.1182/blood-2014-02-554725
Peled JU, Gomes ALC, Devlin SM, Littmann ER, Taur Y, Sung AD, et al. Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation. N. Engl J Med. 2020;382:822–34.
pubmed: 32101664 pmcid: 7534690 doi: 10.1056/NEJMoa1900623
Byrd AL, Belkaid Y, Segre JA. The human skin microbiome. Nat Rev Microbiol. 2018;16:143–55.
pubmed: 29332945 doi: 10.1038/nrmicro.2017.157
Nakatsuji T, Hata TR, Tong Y, Cheng JY, Shafiq F, Butcher AM, et al. Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial. Nat Med. 2021;27:700–9.
pubmed: 33619370 doi: 10.1038/s41591-021-01256-2
Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18:295–304.
pubmed: 4153799 doi: 10.1097/00007890-197410000-00001
Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transpl. 2005;11:945–56.
doi: 10.1016/j.bbmt.2005.09.004
Herlemann DP, Labrenz M, Jürgens K, Bertilsson S, Waniek JJ, Andersson AF. Transitions in bacterial communities along the 2000 km salinity gradient of the Baltic Sea. Isme j. 2011;5:1571–9.
pubmed: 21472016 pmcid: 3176514 doi: 10.1038/ismej.2011.41
Pjevac P, Hausmann B, Schwarz J, Kohl G, Herbold CW, Loy A, et al. An Economical and Flexible Dual Barcoding, Two-Step PCR Approach for Highly Multiplexed Amplicon Sequencing. Front Microbiol. 2021;12:669776.
pubmed: 34093488 pmcid: 8173057 doi: 10.3389/fmicb.2021.669776
Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP. DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13:581–3.
pubmed: 27214047 pmcid: 4927377 doi: 10.1038/nmeth.3869
Callahan BJ, Sankaran K, Fukuyama JA, McMurdie PJ, Holmes SP. Bioconductor Workflow for Microbiome Data Analysis: from raw reads to community analyses. F1000Res. 2016;5:1492.
pubmed: 27508062 pmcid: 4955027 doi: 10.12688/f1000research.8986.2
Pruesse E, Peplies J, Glöckner FO. SINA: accurate high-throughput multiple sequence alignment of ribosomal RNA genes. Bioinformatics. 2012;28:1823–9.
pubmed: 22556368 pmcid: 3389763 doi: 10.1093/bioinformatics/bts252
Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013;41:D590–6.
pubmed: 23193283 doi: 10.1093/nar/gks1219
Kasper S, Andersen RHK, Søren M. Karst, Mads Albertsen. mpvis2: an R package to analyse and visualise 16S rRNA amplicon data. bioRxiv. 2019. https://github.com/MadsAlbertsen/ampvis2 .
Jari Oksanen FGB, Michael F, Roeland K, Pierre L, Dan McGlinn, Peter R, et al. Vegan: Community Ecology Package. R Package Version 2.5-7. 2020. http://CRAN.Rproject.org/package=vegan .
Amann R, Fuchs BM. Single-cell identification in microbial communities by improved fluorescence in situ hybridization techniques. Nat Rev Micro. 2008;6:339–48.
doi: 10.1038/nrmicro1888
Trebesius K, Leitritz L, Adler K, Schubert S, Autenrieth IB, Heesemann J. Culture independent and rapid identification of bacterial pathogens in necrotising fasciitis and streptococcal toxic shock syndrome by fluorescence in situ hybridisation. Med Microbiol Immunol. 2000;188:169–75.
pubmed: 10917153 doi: 10.1007/s004300000035
Daims H, Lücker S, Wagner M. daime, a novel image analysis program for microbial ecology and biofilm research. Environ Microbiol. 2006;8:200–13.
pubmed: 16423009 doi: 10.1111/j.1462-2920.2005.00880.x
Picelli S, Faridani OR, Björklund ÅK, Winberg G, Sagasser S, Sandberg R. Full-length RNA-seq from single cells using Smart-seq2. Nat Protoc. 2014;9:171–81.
pubmed: 24385147 doi: 10.1038/nprot.2014.006
Gómez-Sánchez D, Schlötterer C. ReadTools: A universal toolkit for handling sequence data from different sequencing platforms. Mol Ecol Resour. 2018;18:676–80.
pubmed: 29171165 doi: 10.1111/1755-0998.12741
Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15–21.
pubmed: 23104886 doi: 10.1093/bioinformatics/bts635
Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25:2078–9.
pubmed: 19505943 pmcid: 2723002 doi: 10.1093/bioinformatics/btp352
Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923–30.
pubmed: 24227677 doi: 10.1093/bioinformatics/btt656
Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.
pubmed: 25516281 pmcid: 4302049 doi: 10.1186/s13059-014-0550-8
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.
pubmed: 25605792 pmcid: 4402510 doi: 10.1093/nar/gkv007
Brüggen M-C, Klein I, Greinix H, Bauer W, Kuzmina Z, Rabitsch W, et al. Diverse T-cell responses characterize the different manifestations of cutaneous graft-versus-host disease. Blood. 2014;123:290–9.
pubmed: 24255916 doi: 10.1182/blood-2013-07-514372
Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal. 2011;17:10–2.
Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol. 2012;19:455–77.
pubmed: 22506599 pmcid: 3342519 doi: 10.1089/cmb.2012.0021
Parks DH, Imelfort M, Skennerton CT, Hugenholtz P, Tyson GW. CheckM: assessing the quality of microbial genomes recovered from isolates, single cells, and metagenomes. Genome Res. 2015;25:1043–55.
pubmed: 25977477 pmcid: 4484387 doi: 10.1101/gr.186072.114
Jain C, Rodriguez-R LM, Phillippy AM, Konstantinidis KT, Aluru S. High throughput ANI analysis of 90K prokaryotic genomes reveals clear species boundaries. Nat Commun. 2018;9:5114.
pubmed: 30504855 pmcid: 6269478 doi: 10.1038/s41467-018-07641-9
Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics. 2014;30:2068–9.
pubmed: 24642063 doi: 10.1093/bioinformatics/btu153
Lechner M, Findeiß S, Steiner L, Marz M, Stadler PF, Prohaska SJ. Proteinortho: Detection of (Co-)orthologs in large-scale analysis. BMC Bioinforma. 2011;12:124.
doi: 10.1186/1471-2105-12-124
Casson CN, Yu J, Reyes VM, Taschuk FO, Yadav A, Copenhaver AM, et al. Human caspase-4 mediates noncanonical inflammasome activation against gram-negative bacterial pathogens. Proc Natl Acad Sci. 2015;112:6688.
pubmed: 25964352 pmcid: 4450384 doi: 10.1073/pnas.1421699112
Alloatti A, Kotsias F, Pauwels A-M, Carpier J-M, Jouve M, Timmerman E, et al. Toll-like Receptor 4 Engagement on Dendritic Cells Restrains Phago-Lysosome Fusion and Promotes Cross-Presentation of Antigens. Immunity. 2015;43:1087–100.
pubmed: 26682983 doi: 10.1016/j.immuni.2015.11.006
Buschow SI, Lasonder E, Szklarczyk R, Oud MM, de Vries IJM, Figdor CG. Unraveling the human dendritic cell phagosome proteome by organellar enrichment ranking. J Proteom. 2012;75:1547–62.
doi: 10.1016/j.jprot.2011.11.024
Li S, Paulsson KM, Chen S, Sjögren HO, Wang P. Tapasin is required for efficient peptide binding to transporter associated with antigen processing. J Biol Chem. 2000;275:1581–6.
pubmed: 10636848 doi: 10.1074/jbc.275.3.1581
Montoya M, Schiavoni G, Mattei F, Gresser I, Belardelli F, Borrow P, et al. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood. 2002;99:3263–71.
pubmed: 11964292 doi: 10.1182/blood.V99.9.3263
Simmons DP, Wearsch PA, Canaday DH, Meyerson HJ, Liu YC, Wang Y, et al. Type I IFN Drives a Distinctive Dendritic Cell Maturation Phenotype That Allows Continued Class II MHC Synthesis and Antigen Processing. J Immunol. 2012;188:3116–26.
pubmed: 22371391 doi: 10.4049/jimmunol.1101313
Gérard A, Patino-Lopez G, Beemiller P, Nambiar R, Ben-Aissa K, Liu Y, et al. Detection of rare antigen-presenting cells through T cell-intrinsic meandering motility, mediated by Myo1g. Cell. 2014;158:492–505.
pubmed: 25083865 pmcid: 4119593 doi: 10.1016/j.cell.2014.05.044
Efremova M, Vento-Tormo M, Teichmann SA, Vento-Tormo R. CellPhoneDB: inferring cell–cell communication from combined expression of multi-subunit ligand–receptor complexes. Nat Protoc. 2020;15:1484–506.
pubmed: 32103204 doi: 10.1038/s41596-020-0292-x
Golob JL, Pergam SA, Srinivasan S, Fiedler TL, Liu C, Garcia K, et al. Stool Microbiota at Neutrophil Recovery Is Predictive for Severe Acute Graft vs Host Disease After Hematopoietic Cell Transplantation. Clin Infect Dis. 2017;65:1984–91.
pubmed: 29020185 pmcid: 5850019 doi: 10.1093/cid/cix699
Spindelboeck W, Schulz E, Uhl B, Kashofer K, Aigelsreiter A, Zinke-Cerwenka W, et al. Repeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory gastrointestinal graft-versus-host-disease. Haematologica. 2017;102:e210–3.
pubmed: 28154090 pmcid: 5477627 doi: 10.3324/haematol.2016.154351
van Lier YF, Davids M, Haverkate NJE, de Groot PF, Donker ML, Meijer E, et al. Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients. Sci Transl Med. 2020;12:eaaz8926.
Holler E, Butzhammer P, Schmid K, Hundsrucker C, Koestler J, Peter K, et al. Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease. Biol Blood Marrow Transpl. 2014;20:640–5.
doi: 10.1016/j.bbmt.2014.01.030
Biagi E, Zama D, Nastasi C, Consolandi C, Fiori J, Rampelli S, et al. Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCT. Bone Marrow Transpl. 2015;50:992–8.
doi: 10.1038/bmt.2015.16
Jenq RR, Taur Y, Devlin SM, Ponce DM, Goldberg JD, Ahr KF, et al. Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease. Biol Blood Marrow Transpl. 2015;21:1373–83.
doi: 10.1016/j.bbmt.2015.04.016
Gu Y, Sun J, Li K, Wu X, Zhang J. Alteration in the Skin Microbiome in Cutaneous Graft Versus Host Disease. Acta Derm Venereol. 2021;101:adv00374.
pubmed: 32812057 doi: 10.2340/00015555-3613
Ghimire S, Weber D, Mavin E, Wang Xn, Dickinson AM, Holler E. Pathophysiology of GvHD and Other HSCT-Related Major Complications. Front Immunol. 2017;8:79.
Lei YM, Sepulveda M, Chen L, Wang Y, Pirozzolo I, Theriault B, et al. Skin-restricted commensal colonization accelerates skin graft rejection. JCI Insight. 2019;5:e127569.
Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L, Ferrara JLM. Total Body Irradiation and Acute Graft-Versus-Host Disease: The Role of Gastrointestinal Damage and Inflammatory Cytokines. Blood. 1997;90:3204–13.
pubmed: 9376604 doi: 10.1182/blood.V90.8.3204
Nestel FP, Price KS, Seemayer TA, Lapp WS. Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease. J Exp Med. 1992;175:405–13.
pubmed: 1732411 doi: 10.1084/jem.175.2.405
Penack O, Smith OM, Cunningham-Bussel A, Liu X, Rao U, Yim N, et al. NOD2 regulates hematopoietic cell function during graft-versus-host disease. J Exp Med. 2009;206:2101–10.
pubmed: 19737867 pmcid: 2757869 doi: 10.1084/jem.20090623
Heimesaat MM, Nogai A, Bereswill S, Plickert R, Fischer A, Loddenkemper C, et al. MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease. Gut. 2010;59:1079–87.
pubmed: 20639251 doi: 10.1136/gut.2009.197434
Williams MR, Cau L, Wang Y, Kaul D, Sanford JA, Zaramela LS, et al. Interplay of Staphylococcal and Host Proteases Promotes Skin Barrier Disruption in Netherton Syndrome. Cell Rep. 2020;30:2923–33.e7.
pubmed: 32130897 pmcid: 7183042 doi: 10.1016/j.celrep.2020.02.021

Auteurs

Nadine Bayer (N)

Department of Dermatology, Medical University of Vienna, 1090, Vienna, Austria.
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090, Vienna, Austria.

Bela Hausmann (B)

Joint Microbiome Facility of the Medical University of Vienna and the University of Vienna, 1030, Vienna, Austria.
Division of Clinical Microbiology, Department of Laboratory Medicine, Medical University of Vienna, 1090, Vienna, Austria.

Ram Vinay Pandey (RV)

Department of Dermatology, Medical University of Vienna, 1090, Vienna, Austria.

Florian Deckert (F)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090, Vienna, Austria.
Department of Medicine I, Laboratory of Infection Biology, Medical University of Vienna, 1090, Vienna, Austria.

Laura-Marie Gail (LM)

Department of Dermatology, Medical University of Vienna, 1090, Vienna, Austria.
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090, Vienna, Austria.
Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, 1090, Vienna, Austria.

Johanna Strobl (J)

Department of Dermatology, Medical University of Vienna, 1090, Vienna, Austria.
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090, Vienna, Austria.

Petra Pjevac (P)

Joint Microbiome Facility of the Medical University of Vienna and the University of Vienna, 1030, Vienna, Austria.
Division of Microbial Ecology, Department of Microbiology and Ecosystem Science, Centre for Microbiology and Environmental Systems Science, University of Vienna, 1030, Vienna, Austria.

Christoph Krall (C)

Centre for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, 1090, Vienna, Austria.

Luisa Unterluggauer (L)

Department of Dermatology, Medical University of Vienna, 1090, Vienna, Austria.

Anna Redl (A)

Department of Dermatology, Medical University of Vienna, 1090, Vienna, Austria.
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090, Vienna, Austria.

Victoria Bachmayr (V)

Department of Dermatology, Medical University of Vienna, 1090, Vienna, Austria.

Lisa Kleissl (L)

Department of Dermatology, Medical University of Vienna, 1090, Vienna, Austria.
Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, 1090, Vienna, Austria.

Marion Nehr (M)

Division of Clinical Microbiology, Department of Laboratory Medicine, Medical University of Vienna, 1090, Vienna, Austria.

Rasmus Kirkegaard (R)

Joint Microbiome Facility of the Medical University of Vienna and the University of Vienna, 1030, Vienna, Austria.
Division of Microbial Ecology, Department of Microbiology and Ecosystem Science, Centre for Microbiology and Environmental Systems Science, University of Vienna, 1030, Vienna, Austria.

Athanasios Makristathis (A)

Division of Clinical Microbiology, Department of Laboratory Medicine, Medical University of Vienna, 1090, Vienna, Austria.

Martin L Watzenboeck (ML)

Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Robert Nica (R)

TissueGnostics GmbH, 1020, Vienna, Austria.

Clement Staud (C)

Division of Plastic and Reconstructive Surgery, Department of Surgery, Medical University of Vienna, 1090, Vienna, Austria.

Lukas Hammerl (L)

Department of Dermatology, Medical University of Vienna, 1090, Vienna, Austria.

Philipp Wohlfarth (P)

Department of Internal Medicine I, Hematopoietic Stem Cell Transplantation Unit, Medical University of Vienna, 1090, Vienna, Austria.

Rupert C Ecker (RC)

TissueGnostics GmbH, 1020, Vienna, Austria.
School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD 4059, Australia.

Sylvia Knapp (S)

Department of Medicine I, Laboratory of Infection Biology, Medical University of Vienna, 1090, Vienna, Austria.

Werner Rabitsch (W)

Department of Internal Medicine I, Hematopoietic Stem Cell Transplantation Unit, Medical University of Vienna, 1090, Vienna, Austria.

David Berry (D)

Joint Microbiome Facility of the Medical University of Vienna and the University of Vienna, 1030, Vienna, Austria.
Division of Microbial Ecology, Department of Microbiology and Ecosystem Science, Centre for Microbiology and Environmental Systems Science, University of Vienna, 1030, Vienna, Austria.

Georg Stary (G)

Department of Dermatology, Medical University of Vienna, 1090, Vienna, Austria. georg.stary@meduniwien.ac.at.
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090, Vienna, Austria. georg.stary@meduniwien.ac.at.
Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, 1090, Vienna, Austria. georg.stary@meduniwien.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH